Dolby Labs (DLB) Morgan Stanley 8.2% stake; Atlanta Capital 6.4% reported

Rhea-AI Filing Summary

Dolby Laboratories, Inc. Schedule 13G/A Amendment No. 5 reports beneficial ownership stakes held by Morgan Stanley reporting units and Atlanta Capital Management Company, LLC. The filing lists 5,020,777 shares (8.2%) attributed to Morgan Stanley reporting units and 3,925,085 shares (6.4%) attributed to Atlanta Capital Management. The cover shows Class A Common Stock (CUSIP 25659T107) and includes signed joint filing and Item 7 exhibits. Signatures are dated 05/11/2026.

Insights

Securities Governance Counsel

Filing documents institutional beneficial ownership percentages and joint reporting.

The Schedule 13G/A amendment identifies Morgan Stanley reporting units with 4,230,948 shared voting power and 4,819,090 shared dispositive power, and lists 5,020,777 shares beneficially owned (8.2%).

The filing is joint with Atlanta Capital Management Company, LLC, which reports 3,516,715 shared voting power, 3,734,611 shared dispositive power, and 3,925,085 shares (6.4%). The document includes a Joint Filing Agreement and Item 7 exhibit describing MS Reporting Units.

Institutional Ownership Analyst

Two institutional holders report sizable passive stakes in Dolby Class A shares.

The amendment frames the positions as joint reporting by specific units: Morgan Stanley's MS Reporting Units are disclosed separately per the referenced Release, and Atlanta Capital's filings are similarly enumerated. The filing uses shared voting/dispositive columns to show control attributes.

Cash‑flow treatment or plans to transact are not stated; subsequent schedule filings would show any changes in direction or magnitude.

Key Figures

Morgan Stanley beneficially owned: 5,020,777 shares Morgan Stanley percent of class: 8.2% Morgan Stanley shared voting power: 4,230,948 shares +5 more

8 metrics

Morgan Stanley beneficially owned 5,020,777 shares Class A Common Stock, Amendment No.5

Morgan Stanley percent of class 8.2% Percent of Class A Common Stock

Morgan Stanley shared voting power 4,230,948 shares Item 6 response on cover page

Morgan Stanley shared dispositive power 4,819,090 shares Item 8 response on cover page

Atlanta Capital beneficially owned 3,925,085 shares Class A Common Stock, Amendment No.5

Atlanta Capital percent of class 6.4% Percent of Class A Common Stock

Atlanta Capital shared voting power 3,516,715 shares Item 6 response on cover page

Atlanta Capital shared dispositive power 3,734,611 shares Item 8 response on cover page

Key Terms

beneficially owned, shared dispositive power, MS Reporting Units, Joint Filing Agreement

4 terms

beneficially owned regulatory

"Amount beneficially owned: See the response(s) to Item 9 on the attached cover page(s)."

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

shared dispositive power regulatory

"Shared Dispositive Power 4,819,090.00"

MS Reporting Units regulatory

"securities beneficially owned...by certain operating units (collectively, the "MS Reporting Units")"

Joint Filing Agreement legal

"EXHIBIT NO. 99.1 Joint Filing Agreement"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 5)

Dolby Laboratories, Inc.

(Name of Issuer)

Class A Common Stock

(Title of Class of Securities)

25659T107

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 25659T107

1

Names of Reporting Persons

Morgan Stanley

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,230,948.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,819,090.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

5,020,777.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.2 %

12

Type of Reporting Person (See Instructions)

HC, CO

SCHEDULE 13G

CUSIP Number(s): 25659T107

1

Names of Reporting Persons

Atlanta Capital Management Company, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 3,516,715.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 3,734,611.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,925,085.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.4 %

12

Type of Reporting Person (See Instructions)

IA, CO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Dolby Laboratories, Inc.
(b)	Address of issuer's principal executive offices: 1275 MARKET STREET, SAN FRANCISCO, CA, 94103
Item 2.
(a)	Name of person filing: 1: Morgan Stanley 2: Atlanta Capital Management Company, LLC
(b)	Address or principal business office or, if none, residence: 1: 1585 Broadway, New York, NY 10036 ;2: 1075 Peachtree Street, Suite 2100, Atlanta, GA 30309
(c)	Citizenship: 1: Delaware 2: Delaware
(d)	Title of class of securities: Class A Common Stock
(e)	CUSIP No.: 25659T107
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See the response(s) to Item 9 on the attached cover page(s).
(b)	Percent of class: 8.2 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See the response(s) to Item 5 on the attached cover page(s).
	(ii) Shared power to vote or to direct the vote: See the response(s) to Item 6 on the attached cover page(s).
	(iii) Sole power to dispose or to direct the disposition of: See the response(s) to Item 7 on the attached cover page(s).
	(iv) Shared power to dispose or to direct the disposition of: See the response(s) to Item 8 on the attached cover page(s).
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Exhibit 99.2
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. * In Accordance with the Securities and Exchange Commission Release No. 34-39538 (January 12, 1998) (the "Release"), this filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by certain operating units (collectively, the "MS Reporting Units") of Morgan Stanley and its subsidiaries and affiliates (collectively, "MS"). This filing does not reflect securities, if any, beneficially owned by any operating units of MS whose ownership of securities is disaggregated from that of the MS Reporting Units in accordance with the Release.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Morgan Stanley

Signature:	Claire Gordon
Name/Title:	Authorized Signatory, Morgan Stanley
Date:	05/11/2026

Atlanta Capital Management Company, LLC

Signature:	Kelly Williams
Name/Title:	Authorized Signatory, Atlanta Capital Management Company, LLC
Date:	05/11/2026

Exhibit Information

EXHIBIT NO. EXHIBITS ------------------ ------------------------------------ 99.1 Joint Filing Agreement 99.2 Item 7 Information * Attention. Intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001).

FAQ

What does Dolby Laboratories' Schedule 13G/A Amendment No. 5 report?

It reports institutional beneficial ownership by Morgan Stanley reporting units and Atlanta Capital Management. The filing lists 5,020,777 shares (8.2%) for Morgan Stanley and 3,925,085 shares (6.4%), with joint filing exhibits.

Who are the reporting persons named in the 13G/A for DLB?

The filing names Morgan Stanley (MS Reporting Units) and Atlanta Capital Management Company, LLC, with principal addresses in New York and Atlanta and signatures dated 05/11/2026.

What voting and dispositive powers are disclosed for Morgan Stanley?

Morgan Stanley's cover responses show 4,230,948 shared voting power and 4,819,090 shared dispositive power tied to the reported 5,020,777 shares representing 8.2% of the class in this filing.

Does the filing indicate these are joint filings or aggregated holdings?

Yes. The filing includes a Joint Filing Agreement (Exhibit 99.1) and notes the securities are reported for certain MS operating units (the "MS Reporting Units") with an Item 7 exhibit describing subsidiary identification.

Are transaction intentions or trading plans disclosed in this amendment?

No. The amendment reports beneficial ownership amounts, voting and dispositive power figures, and exhibits; it does not state any plans to buy, sell, or otherwise transact shares in this excerpt.